News

/News

CURE welcomes WCHN Biomedical Research Institute

The vision of the Western Connecticut Health Network’s (WCHN) Biomedical Research Institute (BRI) is to advance the health of the community by performing innovative translational research currently in human cancer and Lyme disease with the goal of improving standard of patient care ...​ more A recent newspaper article highlights the work of Dr. John Matignetti, a cancer geneticist at the Icahn School of Medicine at Mount Sinai in Manhattan, and the Director of the Western Connecticut Health Network’s Laboratory for Translational Research ... more The research paper discussed in the newspaper article is available here ... more

By |March 3rd, 2017|News|0 Comments

CURE welcomes new member Southern Research

Southern Research is a not-for-profit 501(c)(3) scientific and engineering research organization that conducts preclinical drug discovery and development, advanced engineering research in materials, systems development, and energy and environment research. Southern Research Drug Development division provides preclinical services to pharmaceutical and biotechnology companies and offers a range of services and scientific expertise required for the design, execution and documentation of studies during all phases of preclinical drug development more

By |March 3rd, 2017|News|0 Comments

Talent sought for growing Connecticut bio sector

UConn is seeking qualified candidates for the new position of Technology Incubation Program (TIP), Director, reporting to a University Director within the Technology Commercialization Services group of the Office of the Vice President for Research​ ... more FreeThink Technologies is a rapidly growing company with the mission to be the world leader in the science and technology of stability.  The company seeks a full-time Laboratory Scientist for its Branford laboratories ... more Intensity Therapeutics, Inc. is a private, clinical stage, biotechnology company developing a novel drug treatment for cancer. They seek an experienced manager to the conduct its accounting, controlling, financial [...]

By |March 3rd, 2017|News|0 Comments

Pfizer weighs sales to raise dealmaking funds

Pfizer is considering sale of a portfolio of meds that includes treatments in cardiology, urology and primary care, Bloomberg reports. The company has brought on JPMorgan Chase & Co. to advise it on the process. Divesting the stable of meds, which generate sales of more than $700 million—about 40% of which come from the U.S., and another 45% from Europe—could net Pfizer more than $2 billion. more

By |March 3rd, 2017|News|0 Comments

NSF, USDA to award microbiome research grants

The National Science Foundation and the US Department of Agriculture have awarded $2.1 million in grants to support a series of early-stage microbiome research projects. The grants, which are each worth roughly $300,000, are being provided through the NSF's Early Concept Grants for Exploratory Research (EAGER) program in partnership with the USDA's National Institute of Food and Agriculture. more

By |February 12th, 2017|News|0 Comments

Acclaimed geneticist to join UConn and Jax

Se-Jin Lee, M.D., Ph.D., an internationally renowned geneticist focused on discovering causes and cures for muscle degenerative diseases like muscular dystrophy and muscle wasting conditions resulting from diseases such as cancer and sepsis, will join UConn Health and The Jackson Laboratory (JAX) as a joint faculty appointment. Lee will begin his role as Presidential Distinguished Professor at UConn School of Medicine and professor at JAX this summer. Lee is the third joint faculty member appointed by UConn and The Jackson Laboratory for Genomic Medicine, both located Farmington. more

By |February 12th, 2017|News|0 Comments

Medtronic wins coverage for leadless pacemaker

Medtronic has secured Medicare coverage for its leadless pacemaker. The Centers for Medicare & Medicaid Services agreed to cover the device through its Coverage with Evidence Development, a policy that adds products to Medicare provided the manufacturer generates additional data. more

By |February 12th, 2017|News|0 Comments

UK government courts life sciences sector

The U.K. government wants to strike a deal to boost the productivity of the life science sector. Officials have called on business and academia to team up and pitch proposals for how the increasingly interventionist government can fix the problems they face. more

By |February 12th, 2017|News|0 Comments

North Haven rep introduces bill to lure biotechs

CT State Representative David Yaccarino of North Haven has sponsored several bills that would make it easier for bioscience or biotechnology companies to do business in Connecticut. One establishes a biotechnology and bioscience investment tax credit program that gives a 50 percent tax credit on investments made to qualified biotechnology and bioscience companies. Another bill Yaccarino is co-sponsoring exempts companies from the corporation business tax for five years if they relocate from an out-of-state academic business incubator and are partnered with an accredited post-secondary institution.​ more

By |February 12th, 2017|News|0 Comments

Jackson Lab seeks postdocs in computational genetics

The Jackson Laboratory – Dr. Greg Carter is seeking Postdoctoral candidates in computational genetics and systems biology to develop computational methods that derive biological models from large-scale genetic and genomics data. Successful candidates will join either the laboratory of Dr. Carter at the Farmington, CT campus of The Jackson Laboratory for Genomic Medicine, or his lab at The Jackson Laboratory for Mammalian Genetics in Bar Harbor, ME. more

By |February 12th, 2017|News|0 Comments